|
|
Volumn 9, Issue 4, 1999, Pages 208-210
|
|
Two challenges for research ethics: Innovative treatment and fetal therapy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CORTICOSTEROID;
UTERUS SPASMOLYTIC AGENT;
CLINICAL RESEARCH;
ETHICS;
FEMALE;
FETUS;
FETUS LUNG MATURITY;
FETUS MONITORING;
FETUS RISK;
FETUS SURGERY;
HUMAN;
INFORMED CONSENT;
NOTE;
PREGNANCY;
PREMATURE LABOR;
AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
FETAL RESEARCH;
FETAL THERAPY;
GENETICS AND REPRODUCTION;
INVESTIGATIONAL THERAPIES;
NONTHERAPEUTIC RESEARCH;
OBSTETRICS AND GYNECOLOGY;
PREGNANT WOMEN;
PROFESSIONAL ORGANIZATIONS;
RESEARCH SUBJECTS;
RISKS AND BENEFITS;
THERAPEUTIC RESEARCH;
ETHICS, MEDICAL;
FEMALE;
FETAL DISEASES;
FETAL RESEARCH;
GUIDELINES;
HUMANS;
NONTHERAPEUTIC HUMAN EXPERIMENTATION;
PREGNANCY;
PREGNANT WOMEN;
RESEARCH;
RESEARCH SUBJECTS;
RISK ASSESSMENT;
THERAPEUTIC HUMAN EXPERIMENTATION;
THERAPIES, INVESTIGATIONAL;
UNITED STATES;
|
|
EID: 0032804824
PISSN: 10493867
EISSN: None
Source Type: Journal
DOI: 10.1016/S1049-3867(99)00013-4 Document Type: Note |
|
Times cited : (4)
|
|
References (14)
|
